If this drug can actually tackle the obesity epidemic for good then surely its manufacturer is worth investing in.
https://www.google.com/amp/s/nortonhealthcare.com/news/wegovy-new-weight-loss-drug/amp/
It was approved by the FDA in 2021 and the NHS in the UK approved it in Feb.
Can anyone see any downsides at all to this stock?
Leave a Reply